Xenetic Biosciences Inc（纳斯达克代码：XBIO）今日宣布，其合并后的实体预计将继续在纳斯达克资本市场挂牌交易，并以全新名称Santersus Bio, Inc.示人。此番变动，伴随而来的是股票代码的更新——公司将启用“SNTS”作为新的交易代码。
这一战略性整合举措，标志着公司在发展历程中迈出了关键一步。合并完成后，新实体将承载起更为宏大的商业蓝图，而交易代码的更迭，则为投资者识别和追踪这一转型中的企业提供了清晰的标识。市场参与者正密切关注这一过渡进程，期待新公司在资本市场的表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.